Role of the parathyroid gland vascularization index in predicting percutaneous ethanol injection efficacy in refractory uremic hyperparathyroidism

Nephron - Clinical Practice

Volumn 117, Issue 2, 2011, Pages

  Chen, Han Hsiang ^a,b   Lu, Kuo Cheng ^d   Lin, Cheng Jui ^a,b   Wu, Chih Jen ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Mackay Medicine   (Australia)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Chronic renal failure; Parathyroid hormone; Percutaneous ethanol injection therapy; Secondary hyperparathyroidism

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; COMPUTER PROGRAM; DISEASE MARKER; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; MALE; PARATHYROID GLAND; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; UREMIC HYPERPARATHYROIDISM; VASCULARIZATION;

CHRONIC DISEASE; DIALYSIS; ETHANOL; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UREMIA;

EID: 77955204263     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319659     Document Type: Article

References (21)

1. Dusso AS, Sato T, Arcidiacono MV, Alvarez-Hernandez D, Yang J, Gonzalez-Suarez I, et al: Pathogenic mechanisms for parathyroid hyperplasia. Kidney Int Suppl 2006;102: S8-S11.
2. Hruska KA, Teitelbaum SL: Renal osteodystrophy. N Engl J Med 1995;333:166-174.
3. Lewin E, Olgaard K: Influence of parathyroid mass on the regulation of PTH secretion. Kidney Int Suppl 2006;102: S16-S21.
4. Onoda N, Kashiwagi T, Nakamura T, Niitsu Y, Omata M, Kurihara S: Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients. Ther Apher Dial 2005;9: S11-S15.
5. Solbiati L, Giangrande A, De Pra L, Bellotti E, Cantu P, Ravetto C: Percutaneous ethanol injection of parathryoid tumors under us guidance: treatment for secondary hyperparathyroidism. Radiology 1985;155:607-610.
6. Kakuta T, Fukagawa M, Fujisaki T, Hida M, Suzuki H, Sakai H, et al: Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999;33:1091-1099.
7. Nakamura M, Fuchinoue S, Teraoka S: Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism. Am J Kidney Dis 2003;42:739-745.
8. Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M: Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines. Ther Apher Dial 2005;9:48-52.
9. Douthat WG, Orozco SE, de Arteaga J, Massari PU: Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int Suppl 2003;63: S101-S104.
10. Tanaka R, Kakuta T, Fujisaki T, Tanaka S, Sakai H, Kurokawa K, et al: Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Nephrol Dial Transplant 2003;18: iii58-iii61.
11. Koiwa F, Kakuta T, Tanaka R, Yumita S: Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2006;22:522-528.
12. Kurjak A, Kupesic S: Clinical Application of 3D Sonography. London, Parthenon, 2000.
13. Pan HA, Cheng YC, Li CH, Wu MH, Chang FM: Ovarian stroma flow intensity decreases by age: a three-dimensional power Doppler ultrasonographic study. Ultrasound Med Biol 2002;28:425-430.
14. Chang RF, Wu WJ, Moon WK, Chen WM, Lee W, Chen DR: Segmentation of breast tumor in three-dimensional ultrasound images using three-dimensional discrete active contour model. Ultrasound Med Biol 2003;29:1571-1581.
15. Pan HA, Wu MH, Cheng YC, Li CH, Chang FM: Quantification of Doppler signal in polycystic ovarian syndrome using 3D power Doppler ultrasonography. Hum Reprod 2002;17:2484.
16. Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kakuta T, Onoda N, Koiwa F, Yumita S, Kurokawa K, Japanese Society for Parathyroid Intervention: Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003;18: S31-S33.
17. Fletcher S, Kanagasundaram NS, Rayner HC, Irving HC, Fowler RC, Brownjohn AM, Turney JH, Will EJ, Davison AM: Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 1998;13:3111-3117.
18. Giangrande A C A, Solbiati L, Allaria P: Ultrasound-guided percutanous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7:412-421.
19. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K: Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994;46:1110-1117.
20. Fassi J, Lambertini R, Farias P, Blejman O, Rosa Diez G, Algranati S, et al: Treatment of uremic hyperparathyroidism with percutaneous ethanol injection. Nephron Clin Pract 2005;101: c53-c57.
21. Onoda N, Kurihara S, Sakurai Y, Owada K, Osono E, Adachi H, et al: Eva luation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology. Nephrol Dial Transplant 2003;18: iii34-iii37.